Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


TransCelerate BioPharma Inc.

Latest From TransCelerate BioPharma Inc.

Digital Transformation Of Clinical Trials Is Shared Responsibility, CRO Industry Says

Digitizing data collection and monitoring has taken longer than desired due to various challenges, including resistance to change, unanticipated burdens and trial complexity, officials from ACRO and Medidata say, countering US FDA Commissioner Gottlieb’s criticisms that CRO business practices are holding back change.

Clinical Trials Digital Health

Reliance On ‘Digitized Paper’ Is Slowing Drug Development – US FDA’s Woodcock

Efficient development and review is being hindered by the inability to exchange data freely and truly capitalize on the digital age, CDER director says, challenging industry, regulators and others to creatively think about how to move away from legacy, paper-based processes in clinical trials and regulatory submissions.

Clinical Trials Drug Review

TransCelerate Carves Out New Group For Preclinical Collaboration

Goal is to streamline preclinical development through cross-company sharing of target-based toxicology datasets.

BioPharmaceutical United States

Privacy Reforms Could Speed Trial Enrollment, Stakeholders Tell Congress

Industry says relaxation of HIPPA could take years off drug research and enable new clinical trial networks, but is less willing to de-privatize its own data.

BioPharmaceutical North America
See All